Abstract:Cancer progression involves a variety of pro-tumorigenic biological processes including cell proliferation, migration, invasion, and survival. A cellular pathway implicated in these pro-tumorigenic processes is autophagy, a catabolic route used for recycling of cytoplasmic components to generate macromolecular building blocks and energy, under stress conditions, to remove damaged cellular constituents to adapt to changing nutrient conditions and to maintain cellular homeostasis. During autophagy, cells form a double-membrane sequestering a compartment termed the phagophore, which matures into an autophagosome. Following fusion with the lysosome, the cargo is degraded inside the autolysosomes and the resulting macromolecules released back into the cytosol for reuse. Cancer cells use this recycling system during cancer progression, however the key autophagy players involved in this disease is unclear. Accumulative evidences show that autophagy receptors, crucial players for selective autophagy, are overexpressed during cancer progression, yet the mechanisms whereby pro-tumorigenic biological processes are modulated by these receptors remains unknown. In this review, we summarized the most important findings related with the pro-tumorigenic role of autophagy receptors p62/SQSTM1, NBR1, NDP52, and OPTN in cancer progression. In addition, we showed the most relevant cargos degraded by these receptors that have been shown to function as critical regulators of pro-tumorigenic processes. Finally, we discussed the role of autophagy receptors in the context of the cellular pathways implicated in this disease, such as growth factors signaling, oxidative stress response and apoptosis. In summary, we highlight that autophagy receptors should be considered important players of cancer progression, which could offer a niche for the development of novel diagnosis and cancer treatment strategies.

The role of autophagy in prostate cancer and prostatic diseases: a new therapeutic strategy

Autophagy Regulators As Potential Cancer Therapeutic Agents: A Review

Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response

Prospects of the Role of Autophagy in Tumor Therapy

Autophagy in benign prostatic hyperplasia: insights and therapeutic potential

To eat or not to eat: a critical review on the role of autophagy in prostate carcinogenesis and prostate cancer therapeutics

Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies

Autophagy provides a conceptual therapeutic framework for bone metastasis from prostate cancer

The Molecular Mechanism of Autophagy Associated with Cancers

Autophagy and Its Role in Protein Secretion: Implications for Cancer Therapy

Autophagy in Cancer Therapy: Progress and Issues

Pro-survival autophagy and cancer cell resistance to therapy

The autophagic paradox in cancer therapy

Emerging Autophagy Functions Shape the Tumor Microenvironment and Play a Role in Cancer Progression - Implications for Cancer Therapy

Pro-Tumoral Functions of Autophagy Receptors in the Modulation of Cancer Progression

A perspective on the role of autophagy in cancer

The Role of Autophagy in Erectile Dysfunction

Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics

Autophagy and cancer therapy

Autophagy and the Lysosomal System in Cancer

Role of Autophagy in Breast Cancer and Breast Cancer Stem Cells (Review)